Type to search

Wandercraft Closes $45 Million Series C Financing to Accelerate Delivery of the World’s First Personal Self-Balanced Exoskeleton | Pharmtech Focus
Advent France Biotechnology Launches its Second Fund with a First Close at €86M ($102M) | Pharmtech Focus